CRL vs EHAB · rev $2.00B vs rev $1.03B
Charles River Laboratories (CRL) versus Enhabit Inc. (EHAB) — a side-by-side from cached financials, not a winner call.
Charles River Laboratories (CRL) is a diagnostics & research company listed on US.
Enhabit Inc. (EHAB) is a medical care facilities company listed on NYSE.
Latest reported CRL revenue for 2026-06-27 was $2.00B. Net income was -$16.3M. CRL currently screens at market cap $7.78B.
Latest reported EHAB revenue for 2024-12-31 was $1.03B. Net income was -$154.0M. Revenue was down 1.1% from 2023-12-31 to 2024-12-31. EHAB currently screens at market cap $706.9M.
CRL currently screens at market cap $7.78B. EHAB currently screens at market cap $706.9M.
Not investment advice. Open the CRL and EHAB stock pages for the full models.
Not investment advice.